Cash Flow from Operating Activities: A company's cash flows from operations.
Brainstorm Cell Therapeutics Inc. (BCLI) had Cash Flow from Operating Activities of $-6.97M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.31M |
|
-- |
|
-- |
|
$9.95M |
|
$-9.95M |
|
$-0.35M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-9.95M |
|
$-9.75M |
|
9.27M |
|
9.27M |
|
$-1.11 |
|
$-1.11 |
|
| Balance Sheet Financials | |
$0.31M |
|
$0.23M |
|
$0.71M |
|
$1.02M |
|
$11.01M |
|
-- |
|
-- |
|
$11.01M |
|
$-9.98M |
|
$-9.98M |
|
$-9.98M |
|
11.04M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-6.97M |
$0.00M |
|
$6.88M |
|
$0.37M |
|
$0.28M |
|
$-0.10M |
|
$1.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-- |
|
-0.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
103.22% |
|
103.22% |
|
-1008.51% |
|
103.22% |
|
$-0.90 |
|
$-0.75 |
|
$-0.75 |
|